National Association of Testing Authorities, Australia
Scope of Accreditation
Translational Research Institute - Proteomics Core Facility
Site
TRI – Proteomics Core Facility
Accreditation No.
21222
Site No.
25540
Date of Accreditation
18 Dec 2023
Address
Level 5, , Translational Research Institute, 37 Kent St
Woolloongabba, QLD 4102
Australia
Contact
Availability
Services conditionally available to external clients
Supervision
Not Applicable
Scope of Accreditation
TRI – Proteomics Core Facility
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studiesWet lab work only. Specimens referred by PQ (02639) and results reported by PQ - PAH (02639 02325). | Formalin-fixed paraffin-embedded (FFPE) tissues | Amyloid forming proteins |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
21222
Site No.
25540
Print date
27 Jul 2024
END OF SCOPE
